Microcephalic osteodysplastic primordial dwarfism type II
|Microcephalic osteodysplastic primordial dwarfism type II|
|Classification and external resources|
Microcephalic osteodysplastic primordial dwarfism type II (MOPD II) is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that MOPD, or a subtype of MOPD, affects less than 200,000 people in the US population and a form of dwarfism associated with brain and skeletal abnormalities.
It was characterized in 1982.
- Majewski F, Ranke M, Schinzel A (May 1982). "Studies of microcephalic primordial dwarfism II: the osteodysplastic type II of primordial dwarfism". Am. J. Med. Genet. 12 (1): 23–35. doi:10.1002/ajmg.1320120104. PMID 7201238.
- Rauch A, Thiel CT, Schindler D et al. (February 2008). "Mutations in the pericentrin (PCNT) gene cause primordial dwarfism". Science 319 (5864): 816–9. doi:10.1126/science.1151174. PMID 18174396.